Bloodhound
Every month. The highest-risk firms. Investigated.
Your highest-risk firms, already researched. Each month you get a source-backed briefing on a selected group of the highest-scoring firms Risk Radar rates High: complaints, court and Gazette notices, press coverage, and regulatory and corporate records in one place. Anything reported in an earlier month is marked as already known, so you can see what Bloodhound has added.
Why Look Beyond the Data?
Structured data is powerful for spotting patterns. But complaints, press coverage and regulatory developments explain why a firm is High, and whether it matters to you.
Bloodhound searches those sources for you and brings the evidence together in one place.
See the Output
One report per firm, with the evidence behind every finding.
-
Summary and why the firm is flagged
What was found, plus the Risk Radar reasons behind the High rating. -
Additional external findings vs already known
Findings from earlier briefings are marked, so you can see what each month adds. -
What could and couldn't be checked
Gaps are stated plainly, not papered over. -
Source references
Every finding links to the public material behind it.
A Real Case: ITI Capital Limited
Risk Radar rated ITI Capital High on 19 September 2026. It entered special administration on 25 September. Bloodhound then examined the public record and built the chronology below, the kind of briefing you receive for each firm it researches.
This briefing was prepared after the administration, from records that were public beforehand. Risk Radar's High rating was recorded in advance.
What This Means for You
🗂️ The Legwork Is Done Before You Start
No trawling Ombudsman decisions, court judgments, the Gazette, news archives, the FCA Register and Companies House firm by firm. It arrives as one briefing per firm.
🔍 See What the Numbers Can't
A run of upheld complaints, a critical press story, a regulatory development, the context that explains why a firm is High, and whether it matters to you.
📎 Evidence You Can Put in Front of Anyone
Every finding links to its source, so you can check it, file it and show your working to a committee or an auditor.
🆕 Built on What You Already Know
Findings from earlier briefings are marked as already known, so each month's report shows what Bloodhound has added.
✅ Regular Monthly Coverage
Each month Bloodhound researches a selected group of the highest-scoring High-risk companies. No one has to remember to look.
What It Covers
-
FCA Register
Permissions, restrictions and disciplinary history, across every FRN the company holds. -
Ombudsman and compensation
Financial Ombudsman Service decisions and FSCS records. -
Courts and official notices
UK court judgments, The Gazette, GOV.UK, the Pensions Regulator and the Pensions Ombudsman. -
Company announcements
Investegate and London Stock Exchange news. -
Trade press and national media
Credible reporting that standard datasets miss. -
Companies House
Status, filings and ownership, to confirm the right entity.
Why You Can Rely on It
-
Careful company identification
Findings are cross-checked against FCA and Companies House records to reduce the risk of confusing similarly named firms. -
Findings checked against available source evidence
Each date, amount and reference in the written briefing is checked against the evidence gathered before it reaches you. -
Press kept in its place
Press coverage is reported as press context, not stated as fact, unless the article itself has been read. -
You make the call
Bloodhound organises the evidence. It doesn't decide whether a firm is safe or likely to fail.
One-Off Bloodhound Review
£799
An external review of a selected group of the highest-scoring firms Risk Radar rates High. Supplied as an Excel workbook listing the reviewed firms, linking to an individual Bloodhound PDF report for each, with additional findings and the evidence behind them.
Annual Bloodhound Subscription
£2,999 per annum
New reviews every month for 12 months, with an updated workbook and PDF reports. Each report separates existing Risk Radar indicators from the additional findings Bloodhound's research identifies.
You Won't Pay Twice If You Upgrade
Buy the £799 one-off Bloodhound review and move to the £2,999 annual subscription later. We'll credit the full £799 against your subscription, subject to our upgrade terms.